Literature DB >> 11588213

Factors affecting renal function in 119 985 adults over three years.

K Ishida1, H Ishida, M Narita, T Sairenchi, Y Saito, H Fukutomi, H Takahashi, K Yamagata, A Koyama.   

Abstract

Blood pressure, proteinuria and serum creatinine (SCr) were examined in 119 985 adults, aged 40 years and older, who attended annual health examinations both in 1993 and 3 years later. Renal function was assessed from SCr; changes in individuals' renal function were estimated using the slope of the regression line for the reciprocal of the SCr level vs. time (slope of rSCr) over the 3-year period. Age-dependent SCr concentration increments were observed; however, there was no significant age-dependent change in the slope of rSCr. SCr in hypertensives on anti-hypertensive medication was significantly higher than that in untreated hypertensives, borderline hypertensives and normotensives. The slopes of rSCr in hypertensives (treated, untreated and borderline) were steeper than normotensives in males, and that in untreated hypertensives was steeper than other groups in females. In hypertensives with proteinuria, SCr was higher and renal function deteriorated more rapidly, compared with hypertensives without proteinuria. Hypertension with proteinuria appears to be an important indicator for progressive decline in renal function, this trend being more obvious in males. Renal function decreases with age; however, the rate of decline is constant. The influences of proteinuria and blood pressure on renal function are different in males and females.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588213     DOI: 10.1093/qjmed/94.10.541

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

1.  Use of oral bisphosphonates by older adults with fractures and impaired renal function.

Authors:  Cheryl A Sadowski; Tara Spencer; Nese Yuksel
Journal:  Can J Hosp Pharm       Date:  2011-01

Review 2.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 3.  Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists.

Authors:  Paul D Miller
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

4.  Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.

Authors:  Kunihiro Yamagata; Hirofumi Makino; Tadao Akizawa; Kunitoshi Iseki; Sadayoshi Itoh; Kenjiro Kimura; Daisuke Koya; Ichiei Narita; Tetsuya Mitarai; Masanobu Miyazaki; Yoshiharu Tsubakihara; Tsuyoshi Watanabe; Takashi Wada; Osamu Sakai
Journal:  Clin Exp Nephrol       Date:  2009-12-18       Impact factor: 2.801

Review 5.  Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

6.  Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.

Authors:  Kunitoshi Iseki; Masaru Horio; Enyu Imai; Seiichi Matsuo; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-10-15       Impact factor: 2.801

Review 7.  Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Authors:  Kunihiro Yamagata; Kunitoshi Iseki; Kousaku Nitta; Hirokazu Imai; Yasuhiko Iino; Seiichi Matsuo; Hirofumi Makino; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

8.  The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.

Authors:  Jan Skupien; James H Warram; Adam M Smiles; Monika A Niewczas; Tomohito Gohda; Marcus G Pezzolesi; Diego Cantarovich; Robert Stanton; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.